Overexpression of HMGA1 confers radioresistance by transactivating RAD51 in cholangiocarcinoma

[1]  Gang Chen,et al.  Therapy for advanced cholangiocarcinoma: Current knowledge and future potential , 2020, Journal of cellular and molecular medicine.

[2]  G. Gores,et al.  Cholangiocarcinoma 2020: the next horizon in mechanisms and management , 2020, Nature Reviews Gastroenterology & Hepatology.

[3]  Zhaojian Liu,et al.  Mitochondrial superoxide contributes to oxidative stress exacerbated by DNA damage response in RAD51-depleted ovarian cancer cells , 2020, Redox biology.

[4]  Yu Deng,et al.  CtBP1 transactivates RAD51 and confers cisplatin resistance to breast cancer cells , 2020, Molecular carcinogenesis.

[5]  Zhaojian Liu,et al.  MYC-regulated pseudogene HMGA1P6 promotes ovarian cancer malignancy via augmenting the oncogenic HMGA1/2 , 2020, Cell Death and Disease.

[6]  Yen-Yun Wang,et al.  DNA Repair Protein Rad51 Induces Tumor Growth and Metastasis in Esophageal Squamous Cell Carcinoma via a p38/Akt-Dependent Pathway , 2019, Annals of Surgical Oncology.

[7]  G. Poston,et al.  Increased multimodality treatment options has improved survival for Hepatocellular carcinoma but poor survival for biliary tract cancers remains unchanged. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[8]  J. Tabernero,et al.  Extracellular HMGA1 Promotes Tumor Invasion and Metastasis in Triple-Negative Breast Cancer , 2018, Clinical Cancer Research.

[9]  K. Iczkowski,et al.  STAT5A/B Blockade Sensitizes Prostate Cancer to Radiation through Inhibition of RAD51 and DNA Repair , 2018, Clinical Cancer Research.

[10]  E. J. Lee,et al.  Hepatocyte Growth Factor Improves the Therapeutic Efficacy of Human Bone Marrow Mesenchymal Stem Cells via RAD51. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[11]  M. Renna,et al.  High mobility group A1 protein modulates autophagy in cancer cells , 2017, Cell Death and Differentiation.

[12]  Y. Pomyen,et al.  Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma. , 2017, Cancer cell.

[13]  A. Fusco,et al.  High mobility group A1 enhances tumorigenicity of human cholangiocarcinoma and confers resistance to therapy , 2017, Molecular carcinogenesis.

[14]  Cheng Li,et al.  GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses , 2017, Nucleic Acids Res..

[15]  S. Costantini,et al.  The Architectural Chromatin Factor High Mobility Group A1 Enhances DNA Ligase IV Activity Influencing DNA Repair , 2016, PloS one.

[16]  I. Ellis,et al.  Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response protein , 2016, Breast Cancer Research and Treatment.

[17]  K. Boberg,et al.  Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) , 2016, Nature Reviews Gastroenterology &Hepatology.

[18]  A. Fusco,et al.  High mobility group A1 protein expression reduces the sensitivity of colon and thyroid cancer cells to antineoplastic drugs , 2014, BMC Cancer.

[19]  A. Seluanov,et al.  Regulation of Rad51 promoter , 2014, Cell cycle.

[20]  G. Sauter,et al.  RAD51 overexpression is a negative prognostic marker for colorectal adenocarcinoma , 2013, International journal of cancer.

[21]  Suyun Huang,et al.  FoxM1 Inhibition Sensitizes Resistant Glioblastoma Cells to Temozolomide by Downregulating the Expression of DNA-Repair Gene Rad51 , 2012, Clinical Cancer Research.

[22]  L. Cope,et al.  The HMGA1-COX-2 axis: a key molecular pathway and potential target in pancreatic adenocarcinoma. , 2012, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[23]  A. Fusco,et al.  HMGA1 and HMGA2 protein expression correlates with advanced tumour grade and lymph node metastasis in pancreatic adenocarcinoma , 2012, Histopathology.

[24]  A. Seluanov,et al.  Adenoviral Vector Driven by a Minimal Rad51 Promoter Is Selective for p53-Deficient Tumor Cells , 2011, PloS one.

[25]  C. Croce,et al.  HMGA proteins promote ATM expression and enhance cancer cell resistance to genotoxic agents , 2011, Oncogene.

[26]  L. Cope,et al.  HMGA1 Correlates with Advanced Tumor Grade and Decreased Survival in Pancreatic Ductal Adenocarcinoma , 2009, Modern Pathology.

[27]  T. Jacks,et al.  p63 and p73 Transcriptionally Regulate Genes Involved in DNA Repair , 2009, PLoS genetics.

[28]  P. Chieffi,et al.  Interaction between HMGA1 and Retinoblastoma Protein Is Required for Adipocyte Differentiation* , 2009, The Journal of Biological Chemistry.

[29]  P. Cappabianca,et al.  HMGA proteins up-regulate CCNB2 gene in mouse and human pituitary adenomas. , 2009, Cancer research.

[30]  R. Reeves,et al.  High-mobility group A1 proteins inhibit expression of nucleotide excision repair factor xeroderma pigmentosum group A. , 2007, Cancer research.

[31]  Dihua Yu,et al.  Rad51 overexpression contributes to chemoresistance in human soft tissue sarcoma cells: a role for p53/activator protein 2 transcriptional regulation , 2007, Molecular Cancer Therapeutics.

[32]  A. Ashworth,et al.  p53 modulates homologous recombination by transcriptional regulation of the RAD51 gene , 2006, EMBO reports.

[33]  C. Croce,et al.  HMGA1 protein expression sensitizes cells to cisplatin-induced cell death , 2005, Oncogene.

[34]  R. Reeves,et al.  Inhibition of Nucleotide Excision Repair by High Mobility Group Protein HMGA1* , 2005, Journal of Biological Chemistry.

[35]  W. Zhong,et al.  High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patients , 2005, British Journal of Cancer.

[36]  G. D'aiuto,et al.  HMGA1 Protein Overexpression in Human Breast Carcinomas , 2004, Clinical Cancer Research.

[37]  M. Gonen,et al.  Staging, Resectability, and Outcome in 225 Patients With Hilar Cholangiocarcinoma , 2001, Annals of surgery.

[38]  A. Brunetti,et al.  Transcriptional regulation of human insulin receptor gene by the high‐mobility group protein HMGI(Y) , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[39]  H. Stürzbecher,et al.  DNA repair and recombination factor Rad51 is over-expressed in human pancreatic adenocarcinoma , 2000, Oncogene.

[40]  S. Vispé,et al.  Overexpression of Rad51 protein stimulates homologous recombination and increases resistance of mammalian cells to ionizing radiation. , 1998, Nucleic acids research.